Latest Breaking News On - Screening trial - Page 1 : comparemela.com

MicroRNAs Predict Pancreatic Cancer Risk Years in Advance

Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.

Vanderbilt universityUnited statesCong wangInternational journal of cancerVanderbilt university medical centerShanghai women men health studySouthern community cohort studyScreening trialShanghai womenHealth studyMultiethnic cohortCounter analysis systemInternational journalMalignant pancreatic neoplasmPancreatic cancerAncer of the pancreas

Chest X-ray AI analysis potentially predicts ASCVD risk for patients with missing EMR data

Chest X-ray AI analysis potentially predicts ASCVD risk for patients with missing EMR data
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesByscott buzbyJakob weissRichard smithMassachusetts general hospitalScreening trial

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology A

ROCKVILLE, Md. (BUSINESS WIRE) GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American Society of Hematology (ASH) Annual Meeting will feature two presentations o.

Baylor college of medicineUnited statesNew zealand generalNew zealandEdwin rockEmmanuel almanza huanteMicheles redellLeo vartorellaSan diego convention centerCompany annual report on formGlycomimetics incLeukemia lymphoma societyExchange commissionChinese national medical products administrationDrug administrationDepartment of leukemia

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia

GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American.

United statesEdwin rockNew zealand generalNew zealandBaylor college of medicineMicheles redellEmmanuel almanza huanteGlycomimetics incSan diego convention centerChinese national medical products administrationDrug administrationUniversity of texas md anderson cancer centerCompany annual report on formExchange commissionLeukemia lymphoma societyTexas children cancer center

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

North vancouverBritish columbiaUnited statesNew yorkEdwin rockNew zealandBaylor college of medicineBarbara shecterJoe oconnorGabriel friedmanEmmanuel almanza huanteGeoff cookLeo vartorellaMicheles redellCanada revenue agencyAmerican society of hematology